Cardiovascular risk factor prevalence and management in GCA.
| Cardiovascular Risk Factor | At Diagnosis, n (%) | At Last Followup, n (%) |
|---|---|---|
| Dyslipidemia | 37 (53) | 40 (57) |
| Hypertension | 40 (57) | 43 (61) |
| Smoker, ever | 21 (30) | 21 (30) |
| Diabetes | 9 (13) | 10 (14) |
| Coronary artery disease | 5 (7) | 8 (11) |
| History of CVC | 4 (6) | 11 (16) |
| Lipid-lowering therapy | 22 (31) | 31 (44) |
| Antihypertensive medication | 37 (53) | 38 (54) |
| Oral hypoglycemic or insulin | 9 (13) | 9 (13) |
| AP/AC | 31 (44) | 38 (54) |
| Patients with a calculable Framingham risk score at last followup* | 41/70 (59) | |
| Patients not taking statin when indicated by Framingham risk score | 9/42 (21) | |
| Patients taking an AP/AC at last followup | 38/70 (54) | |
| Patients with a CVC while taking AP/AC at last followup | 12/15 (80) |
↵* Patients had a calculable Framingham risk score if necessary variables were available (age, smoking status, history of diabetes, blood pressure, history of fasting lipids within 2 yrs of last followup). GCA: giant cell arteritis; CVC: cardiovascular complication; AP/AC: antiplatelet/anticoagulant.